H.C. Wainwright raised the firm’s price target on Optinose (OPTN) to $18 from $5 and keeps a Buy rating on the shares based on the announced 1-for-15 reverse stock split.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener